/ About / By The Numbers

By The Numbers

An exciting year of expansion – in FY22, OTC grew in size and scope, reaching farther upstream in the innovation pipeline and helping shepherd startups farther downstream.

View our 2022 Annual Report

Duke Start-ups: Impact in North Carolina and Beyond In the Past Five Years

By the Numbers
76
Companies formed
$1.8B
Raised in private and public financing
7
IPOs
9
Acquisitions

Annual Reports

Duke is an innovative place to be – we’re bringing cutting edge research out of the lab and into the world.

See our 2022 Annual Report

See our 2021 Annual Report

See our 2020 Annual Report

See our 2019 Annual Report

See our 2018 Annual Report

2022 Impact

316

Disclosures

107

Agreements

116

Issued Patents

$95.7M

In Revenue

Duke Startups

Duke Total Invention Disclosures & Agreements

Spotlight Stories from FY22

Brain Tumor 'Pied Piper' Device Gains Breakthrough Status,
Exvade Biosciences

“This was the first demonstration that you can engineer migration inside the body and move a tumor from point A to point B by design,”…

Read More
Kriya Expands Gene Therapy Pipeline and Establishes its Rare Disease Therapeutic Area Division with the Acquisition of Warden Bio, Warden Bio

REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — January 7, 2022 — Kriya Therapeutics, Inc., a fully integrated company pioneering novel technologies and therapeutics in gene…

READ MORE >
IonQ Becomes First Publicly Traded, Pure-Play Quantum Computing Company; Closes Business Combination with dMY Technology Group III, IonQ

COLLEGE PARK, Md.–(BUSINESS WIRE), October 1, 2021–IonQ, Inc. (“IonQ” or the “Company”) (NYSE: IONQ), a leader in quantum computing, completed its previously announced business combination…

READ MORE >
Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury, Tellus Therapeutics

DURHAM, N.C.–(BUSINESS WIRE), May 12, 2021–Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter injury (WMI) and myelin repair in…

READ MORE >
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience, Replicate Bioscience

NEW YORK and SAN DIEGO, Sept. 8, 2021 /PRNewswire/ — ATP, a leader in life sciences venture capital, today announced the launch of Replicate Bioscience, a company pioneering ways…

READ MORE >
Sparta Biomedical Receives FDA Breakthrough Device Designation for Biomimetic Implant, Sparta Biomedical

DURHAM, N.C., March 17, 2021 /PRNewswire/ — Sparta Biomedical Inc., a developer of orthopedic solutions, today announced that its SBM-01 Biomimetic Implant has been granted a Breakthrough…

READ MORE >
PowerVerde Completes its Merger with 374Water to Accelerate Delivery of CleanTech to Eliminate PFAS and Recover Resources from Waste and Wastewater, 374Water

MIAMI, April 20, 2021 /PRNewswire/-- PowerVerde Inc. OTCQB (“PWVI”), a Florida-based energy systems developer, and 374Water Inc. (“374Water”), a North Carolina-based cleantech company, today announced the completion…

READ MORE >
Duke spinout with former FDA commissioner on board raises $6M, Clinetic

Triangle Business Journal, February 5, 2021-- A Duke University-born technology firm aimed at connecting hospital data with clinical research is raising millions – and it…

READ MORE >
This Startup Just Raised $70 Million to Grow Tiny Tumors That Create Personalized Cancer Treatments, Xilis

Forbes , July 8, 2021-- Around seven out of ten cancer patients don’t respond to drugs in the first go. This is a hard-hitting statistic…

READ MORE >
Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex, Phitonex

WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham,…

READ MORE >
View All